Expanding Robotic Solutions for Neurological Rehabilitation: Innovations and Growth Plans 00:10:00
Peter Bloch, Chief Executive Officer and Chairman of the Board of Bionik Laboratories. Mr. Bloch continued, “Moving forward, our immediate priorities are to ensure a smooth integration of IMT and Bionik and put forth a robust effort towards our commercialization activities supporting market expansion and revenue generation as well as the advancement and development of our earlier-stage products and technologies towards approval in key markets globally.”
